15 results on '"Tandler R"'
Search Results
2. THE USE OF ROUTINE ENDOMYOCARDIAL BIOPSY FOR DIAGNOSIS OF CELLULAR REJECTION BEYOND 2 YEARS AFTER CARDIAC TRANSPLANTATION: V25
- Author
-
Heim, C., Weyand, M., and Tandler, R.
- Published
- 2014
3. Novacor LVAD bridge to transplantation in peripartum cardiomyopathy
- Author
-
C. Schmid, Michael Weyand, H. H. Scheld, and Tandler R
- Subjects
Pulmonary and Respiratory Medicine ,Adult ,medicine.medical_specialty ,Peripartum cardiomyopathy ,medicine.medical_treatment ,Pregnancy Complications, Cardiovascular ,Pregnancy ,Internal medicine ,medicine ,Humans ,business.industry ,Myocardium ,General Medicine ,Equipment Design ,Puerperal Disorders ,equipment and supplies ,medicine.disease ,Surgery ,Transplantation ,Size mismatch ,Ventricular assist device ,Cardiology ,Heart Transplantation ,Bridge to transplantation ,Female ,Heart-Assist Devices ,Pregnancy, Multiple ,Cardiology and Cardiovascular Medicine ,business ,Cardiomyopathies - Abstract
We report the case of a 22-year-old woman suffering from peripartum cardiomyopathy who was successfully bridged to cardiac transplantation with a Novacor left ventricular assist device (LVAD). Her course with the device is presented and emphasis is put on the size mismatch between the patient and the device, a fact which normally precludes the implantation of the Novacor LVAD.
- Published
- 1997
4. Purification and characterization of an L-amino amidase from Mycobacterium neoaurum ATCC 25795
- Author
-
Hermes, H. F. M., Tandler, R. F., Sonke, T., Lubbert Dijkhuizen, Meijer, E. M., Macromolecular and Organic Chemistry, and Groningen Biomolecular Sciences and Biotechnology
- Subjects
RESOLUTION ,ACIDS - Abstract
An L-amino amidase from Mycobacterium neoaurum ATCC 25795 responsible for the enantioselective resolution of DL-α-methyl valine amide was purified and characterized. The purification procedure included ammonium sulfate fractionation, gel filtration, and anion-exchange chromatography, which resulted in a homogeneous preparation of the enzyme with a native molecular mass of 136 kDa and a subunit molecular mass of 40 kDa. The purified enzyme displayed the highest activity at 50°C and at pH 8.0 and 9.5. The enzyme was strongly inhibited by the metal-chelating agent 1,10-phenanthroline, the disulfide-reducing agent dithiothreitol, and the cysteine proteinase inhibitor iodoacetamide. The purified amino amidase showed a unique L-enantioselective activity towards a broad range of both α-H- and α-alkyl-substituted amino acid amides, with the highest activity towards the cyclic amino acid amide DL-proline amide. No activity was measured with DL-mandelic acid amide nor with the dipeptide L-phenylalanine-L-leucine. The highest catalytic efficiency (kcat/Km ratio) was measured with DL-α-allyl alanine amide, DL-α-methyl phenylalanine amide, and DL-α-methyl leucine amide.
- Published
- 1994
5. Novacor LVAD bridge to transplantation in peripartum cardiomyopathy
- Author
-
Tandler, R, primary
- Published
- 1997
- Full Text
- View/download PDF
6. Successful bridging to cardiac transplantation in a dystrophic infant with the use of a new paracorporeal pneumatic pump
- Author
-
Weyand, M., Kececioglu, D., Schmid, C., Kehl, H.G., Tandler, R., Loick, H.M., and Scheld, H.H.
- Published
- 1997
- Full Text
- View/download PDF
7. Rare Case Report: Left Atrial Sarcoma Obstructing the Left Ventricular Inflow.
- Author
-
Kaemmerer AS, Suleiman MN, Agaimy A, Harig F, Weyand M, and Tandler R
- Abstract
Malignant cardiac tumors of the heart are extremely rare and may present tremendous diagnostic and therapeutic challenges. These tumors are able to infiltrate the heart and metastasize systemically. Early detection is often elusive as the clinical presentation is highly variable, posing significant diagnostic and therapeutic difficulties. Despite a multidisciplinary approach, the prognosis for patients with malignant cardiac tumors remains guarded. Early diagnosis and a multidisciplinary approach involving cardiac surgeons, oncologists and critical care specialists are crucial in the management of this disease. Further research is needed to better understand the pathomechanisms of tumor-related complications and to develop effective treatment strategies to improve patient outcomes. The rare case of a 78-year-old woman with left atrial tumor requiring emergency surgery for acutely developing mitral valve obstruction is presented. Pathology confirmed an undifferentiated pleomorphic sarcoma. This patient tragically did not survive, highlighting the difficulties of managing such a rare and deceptive heart disease.
- Published
- 2023
- Full Text
- View/download PDF
8. Endovascular stenting of an HVAD™ outflow graft pseudoaneurysm that exerts compression and kinking stenosis on the soft portion of the prosthesis.
- Author
-
Elbayomi M, Weyand M, Uder M, May MS, Steger K, Roth JP, and Tandler R
- Abstract
Key Clinical Message: Complex presentations of MCS patients may necessitate a multidisciplinary approach involving HF cardiologists, CT surgeons, advanced cardiac imagers, and interventional cardiologists in order to define the optimal management strategy., Abstract: Left ventricle assist devices (LVADs) provide life-sustaining treatment for patients with terminal heart failure, but their intricacy allows for complications. One complication is LVAD outflow graft obstruction due to the graft's intraluminal thrombus or extraluminal compression. It may be treated endovascularly with stenting. We report an endovascular stenting of an outflow tract in HVAD™ (HeartWare Inc.) due to a pseudoaneurysm causing compression and kinking stenosis., (© 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.)
- Published
- 2023
- Full Text
- View/download PDF
9. Results from a multicentre evaluation of plug use for left ventricular assist device explantation.
- Author
-
Potapov EV, Politis N, Karck M, Weyand M, Tandler R, Walther T, Emrich F, Reichenspurrner H, Bernhardt A, Barten MJ, Svenarud P, Gummert J, Sef D, Doenst T, Tsyganenko D, Loforte A, Schoenrath F, and Falk V
- Subjects
- Device Removal adverse effects, Device Removal methods, Humans, Retrospective Studies, Treatment Outcome, Heart Failure surgery, Heart-Assist Devices adverse effects
- Abstract
Objectives: Myocardial recovery allows for left ventricular assist device (LVAD) explantations after long-term support. Several surgical approaches, including interventional decommissioning, off-pump explantation using a custom-made plug and complete LVAD removal through redo sternotomy, have been described. We present the results from an evaluation of the long-term follow-up of patients who received a titanium sintered plug after LVAD explantation., Methods: We performed a retrospective, European, multicentre analysis of patients who received a titanium sintered plug to seal the apical fixation ring after LVAD explantation. Data were collected from a questionnaire that included demographics, procedural details and follow-up information., Results: Out of 54 contacted centres in 12 countries (n = 179 patients), a total of 68 patients were successfully included in the study. The median follow-up was 34 months (interquartile range: 17-58.5 months); 57 (84%) patients had >1-year follow-up. At the time of the last follow-up, 55 (81%) patients were alive, with a Kaplan-Meier 1-year survival of 90.1% (95% confidence interval: 84.0-98.1%) and a 5-year survival of 80.0% (95% confidence interval: 68.4-92.9%). One patient (1.5%) developed a plug infection originating from an infected part of the incorporated driveline and, after complete removal, is currently in good condition. No postoperative stroke has been reported after plug implantation., Conclusions: In this European multicentre study, the use of a custom-made titanium plug to close the apical fixation ring after LVAD explantation resulted in a low incidence of plug-related complications. With the volume of patients undergoing LVAD explantations after myocardial recovery increasing, the plug has evolved as a simple alternative to more invasive device explantation procedures or decommissioning with a high risk for infection of the remaining system or stroke., (© The Author(s) 2021. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery.)
- Published
- 2022
- Full Text
- View/download PDF
10. Reduction of INCOR® driveline infection rate with silicone at the driveline exit site.
- Author
-
Camboni D, Zerdzitzki M, Hirt S, Tandler R, Weyand M, and Schmid C
- Subjects
- Adult, Female, Humans, Male, Middle Aged, Prevalence, Prospective Studies, Prosthesis-Related Infections epidemiology, Risk Factors, Surgical Wound Infection epidemiology, Heart Failure therapy, Heart-Assist Devices adverse effects, Polyesters, Prosthesis-Related Infections prevention & control, Silicones, Surgical Wound Infection prevention & control
- Abstract
Objectives: A silicone interface at skin level of left ventricular assist device (LVAD) may reduce the risk of driveline (DL) exit site infections when compared with other materials (e.g. velour). The purpose of this study was to evaluate the rate of DL exit site infection according to the presence of silicone or velour at the exit site with the redesigned INCOR, facilitating the positioning of silicone at the exit site., Methods: The rate of DL exit site infection and overall survival were compared between the two groups (silicone group, n = 16/velour group, n = 24) with 1-year follow-up postimplantation., Results: Risk factors for infection were more prevalent in the silicone group (obesity P = 0.33, prevalence of renal dysfunction P = 0.007, higher CRP levels P = 0.001). During the observation period, 6 patients developed a DL infection (25%) in the velour group, whereas 1 patient developed a DL infection in (6%) in the silicone group (P = 0.19). The event-per-patient year (EPPY) rates were 0.34 and 0.10 for velour group and silicone group, respectively (P = 0.30). All DL infections could be treated successfully by the antibiotic treatment, surgical debridement and ultimately high urgency heart transplantation, resulting in no direct DL infection-related mortality in this cohort. One-year survival was similar in both the groups (silicone 69 vs 75% in the velour group; P = 0.67)., Conclusions: Fewer infections were observed at the exit site in case of a silicone-covered DL, without reaching statistical significance. More patients and longer observation periods are needed to demonstrate a statistical difference., (© The Author 2016. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
11. High frequency of Tropheryma whipplei in culture-negative endocarditis.
- Author
-
Geissdörfer W, Moos V, Moter A, Loddenkemper C, Jansen A, Tandler R, Morguet AJ, Fenollar F, Raoult D, Bogdan C, and Schneider T
- Subjects
- Academic Medical Centers, Actinomycetales Infections pathology, Aged, Bacteriological Techniques, Cohort Studies, DNA, Bacterial chemistry, DNA, Bacterial genetics, DNA, Ribosomal chemistry, DNA, Ribosomal genetics, Endocarditis, Bacterial pathology, Female, Germany epidemiology, Heart Valves microbiology, Heart Valves pathology, Histocytochemistry, Humans, Immunohistochemistry, In Situ Hybridization, Fluorescence, Incidence, Male, Microscopy, Middle Aged, Polymerase Chain Reaction, RNA, Ribosomal, 16S genetics, Sequence Analysis, DNA, Actinomycetales Infections epidemiology, Actinomycetales Infections microbiology, Endocarditis, Bacterial epidemiology, Endocarditis, Bacterial microbiology, Tropheryma isolation & purification
- Abstract
"Classical" Whipple's disease (cWD) is caused by Tropheryma whipplei and is characterized by arthropathy, weight loss, and diarrhea. T. whipplei infectious endocarditis (TWIE) is rarely reported, either in the context of cWD or as isolated TWIE without signs of systemic infection. The frequency of TWIE is unknown, and systematic studies are lacking. Here, we performed an observational cohort study on the incidence of T. whipplei infection in explanted heart valves in two German university centers. Cardiac valves from 1,135 patients were analyzed for bacterial infection using conventional culture techniques, PCR amplification of the bacterial 16S rRNA gene, and subsequent sequencing. T. whipplei-positive heart valves were confirmed by specific PCR, fluorescence in situ hybridization, immunohistochemistry, histological examination, and culture for T. whipplei. Bacterial endocarditis was diagnosed in 255 patients, with streptococci, staphylococci, and enterococci being the main pathogens. T. whipplei was the fourth most frequent pathogen, found in 16 (6.3%) cases, and clearly outnumbered Bartonella quintana, Coxiella burnetii, and members of the HACEK group (Haemophilus species, Actinobacillus actinomycetemcomitans, Cardiobacterium hominis, Eikenella corrodens, and Kingella kingae). In this cohort, T. whipplei was the most commonly found pathogen associated with culture-negative infective endocarditis.
- Published
- 2012
- Full Text
- View/download PDF
12. Increased transcript levels of TNF-alpha, TGF-beta, and granzyme B in endomyocardial biopsies correlate with allograft rejection.
- Author
-
Ramsperger-Gleixner M, Spriewald BM, Tandler R, Kondruweit M, Amann K, Weyand M, and Ensminger SM
- Subjects
- Aged, Analysis of Variance, Biopsy, CTLA-4 Antigen genetics, Gene Expression Profiling methods, Germany, Graft Rejection enzymology, Graft Rejection immunology, Graft Rejection pathology, Humans, Interleukin-6 genetics, Male, Middle Aged, Myocardium enzymology, Myocardium pathology, Predictive Value of Tests, Real-Time Polymerase Chain Reaction, Transplantation, Homologous, Up-Regulation, Graft Rejection genetics, Granzymes genetics, Heart Transplantation immunology, Myocardium immunology, RNA, Messenger analysis, Transforming Growth Factor beta genetics, Tumor Necrosis Factor-alpha genetics
- Abstract
Objectives: Endomyocardial biopsies are the criterion standard in diagnosing acute cardiac transplant rejection. This study sought to analyze mRNA expression profiles of various immuneresponse-related genes in endomyocardial biopsies of heart transplant patients and to correlate the results with histologic findings., Materials and Methods: Forty-three biopsies obtained from 6 heart transplant recipients experiencing acute rejection were analyzed for granzyme B, CTLA4, IL-6, TGF-beta, and TNFa expression using real-time polymerase chain reaction. The results were compared with the histologic findings. Biopsies obtained before, during, and after acute rejection episodes were grouped according to the International Society of Heart and Lung Transplantation standard biopsy grading from 1990. Group 1 consisted of biopsies with International Society of Heart and Lung Transplantation grade 0 (n=12), group 2 of International Society of Heart and Lung Transplantation grade 1A (n=14), and group 3 of International Society of Heart and Lung Transplantation grades 1B, 2, 3A, and 4 (n=17)., Results: A strong correlation was seen between histologic groups and gene expression of granzyme B, which showed the highest overall transcript levels. CTLA4 was elevated in group 2, but no further increase in the rejecting group 3 was seen. For IL-6, TGF-beta, and TNFa gene expression was strongly elevated in group 3 compared with groups 1 and 2. On analysis of biopsies with International Society of Heart and Lung Transplantation, grade 0 and 1A, relative to the time point of rejection, we found a substantial increase in mRNA expression of all analyzed immune response-related genes before a rejection episode. The strongest up-regulation was seen for granzyme B, TNFa, and TGF-beta., Conclusions: Our data suggest that analyses of gene expression provides valuable information in diagnosing heart transplant rejection. Furthermore, analyses of granzyme B, TGF-beta, and TNFa might not only confirm an ongoing rejection episode, but also may have a positive predictive value.
- Published
- 2011
13. Stenting of the superior vena cava in a patient with a total artificial heart.
- Author
-
Kondruweit M, Strecker T, Seitz T, Uder M, Weyand M, and Tandler R
- Subjects
- Follow-Up Studies, Heart Failure diagnosis, Humans, Male, Middle Aged, Phlebography, Risk Assessment, Severity of Illness Index, Superior Vena Cava Syndrome diagnostic imaging, Tomography, X-Ray Computed, Treatment Outcome, Vascular Patency, Heart Failure surgery, Heart, Artificial, Stents, Superior Vena Cava Syndrome therapy
- Published
- 2008
- Full Text
- View/download PDF
14. Fatal bioprosthetic aortic valve endocarditis due to Cardiobacterium valvarum.
- Author
-
Geissdörfer W, Tandler R, Schlundt C, Weyand M, Daniel WG, and Schoerner C
- Subjects
- Aged, Anti-Bacterial Agents therapeutic use, Endocarditis, Bacterial diagnosis, Endocarditis, Bacterial drug therapy, Fatal Outcome, Gram-Negative Bacterial Infections diagnosis, Gram-Negative Bacterial Infections drug therapy, Humans, Male, Molecular Sequence Data, Prosthesis-Related Infections diagnosis, Prosthesis-Related Infections drug therapy, Cardiobacterium isolation & purification, Endocarditis, Bacterial microbiology, Gram-Negative Bacterial Infections microbiology, Heart Valve Prosthesis microbiology, Prosthesis-Related Infections microbiology
- Abstract
Cardiobacterium valvarum was isolated from the blood of a 71-year-old man with fatal aortic valve endocarditis. The API NH system was used for phenotypic characterization of the C. valvarum strain. This is the first case of infective endocarditis caused by C. valvarum in Germany and the first case worldwide affecting a prosthetic valve and lacking an obvious dental focus.
- Published
- 2007
- Full Text
- View/download PDF
15. Purification and Characterization of an l-Amino Amidase from Mycobacterium neoaurum ATCC 25795.
- Author
-
Hermes HF, Tandler RF, Sonke T, Dijkhuizen L, and Meijer EM
- Abstract
An l-amino amidase from Mycobacterium neoaurum ATCC 25795 responsible for the enantioselective resolution of dl-alpha-methyl valine amide was purified and characterized. The purification procedure included ammonium sulfate fractionation, gel filtration, and anion-exchange chromatography, which resulted in a homogeneous preparation of the enzyme with a native molecular mass of 136 kDa and a subunit molecular mass of 40 kDa. The purified enzyme displayed the highest activity at 50 degrees C and at pH 8.0 and 9.5. The enzyme was strongly inhibited by the metal-chelating agent 1,10-phenanthroline, the disulfide-reducing agent dithiothreitol, and the cysteine proteinase inhibitor iodoacetamide. The purified amino amidase showed a unique l-enantioselective activity towards a broad range of both alpha-H- and alpha-alkyl-substituted amino acid amides, with the highest activity towards the cyclic amino acid amide dl-proline amide. No activity was measured with dl-mandelic acid amide nor with the dipeptide l-phenylalanine-l-leucine. The highest catalytic efficiency (k(cat)/K(m) ratio) was measured with dl-alpha-allyl alanine amide, dl-alpha-methyl phenylalanine amide, and dl-alpha-methyl leucine amide.
- Published
- 1994
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.